Single Ascending Dose Study of PCSK-9 Inhibitor (IBI306) in Healthy Subjects.
Clinical trial NCT03366688 · COMPLETED
Trial details
- NCT number
- NCT03366688
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-27
- Primary completion
- 2018-11-05
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.